These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15776000)

  • 21. The Global HIV/AIDS pandemic, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Aug; 55(31):841-4. PubMed ID: 16902393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inequalities in health: access to treatment for HIV/AIDS.
    Giuliano M; Vella S
    Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi.
    Kamoto K; Aberle-Grasse J;
    Antivir Ther; 2008; 13 Suppl 2():83-7. PubMed ID: 18575195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delivery of antiretroviral therapy in sub-saharan Africa.
    Weller I
    Clin Infect Dis; 2006 Sep; 43(6):777-8. PubMed ID: 16912955
    [No Abstract]   [Full Text] [Related]  

  • 26. HIV/AIDS: the epidemic, its impact and turning the tide.
    Harries AD
    Int J Tuberc Lung Dis; 2005 May; 9(5):471-4. PubMed ID: 15875914
    [No Abstract]   [Full Text] [Related]  

  • 27. Mothers, midwives, and HIV/AIDS in Sub-Saharan Africa.
    Raisler J; Cohn J
    J Midwifery Womens Health; 2005; 50(4):275-82. PubMed ID: 15973262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa.
    Birbeck G; Chomba E; Ddumba E; Kauye F; Mielke J
    Epilepsia; 2007 Jul; 48(7):1424-5. PubMed ID: 17635568
    [No Abstract]   [Full Text] [Related]  

  • 29. Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.
    Sigaloff KC; Hamers RL; Menke J; Labib M; Siwale M; Ive P; Botes ME; Kityo C; Mandaliya K; Wellington M; Osibogun A; Geskus RB; Stevens WS; van Vugt M; Rinke de Wit TF;
    Clin Infect Dis; 2012 May; 54 Suppl 4():S294-9. PubMed ID: 22544190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of an observational database to assess antiretroviral treatment trends in India.
    Cecelia AJ; Christybai P; Anand S; Jayakumar K; Gurunathan T; Vidya P; Solomon S; Kumarasamy N
    Natl Med J India; 2006; 19(1):14-7. PubMed ID: 16570679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia.
    Abegaz WE; Grossman Z; Wolday D; Ram D; Kaplan J; Sibide K; Wuhib T; Ismael S; Nkengasong J; Mekonen T; Berhanu H; Messele T; Lulseged S; Maayan S; Mengistu Y
    Antivir Ther; 2008; 13 Suppl 2():89-94. PubMed ID: 18575196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are the best antiretrovirals being used in Africa?
    John L; Kambugu A; Songa PM; Castelnuovo B; Colebunders R; Kamya M
    J HIV Ther; 2006 Mar; 11(1):11-5. PubMed ID: 16706250
    [No Abstract]   [Full Text] [Related]  

  • 33. Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999.
    Mocroft A; Horban A; Clotet B; d'Arminio Monforte A; Bogner JR; Aldins P; Staub T; Antunes F; Katlama C; Lundgren JD;
    HIV Med; 2008 Jan; 9(1):41-6. PubMed ID: 18199171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The real challenges for scaling up ART in sub-Saharan Africa.
    Van Damme W; Kober K; Laga M
    AIDS; 2006 Mar; 20(5):653-6. PubMed ID: 16514294
    [No Abstract]   [Full Text] [Related]  

  • 35. As the tide turns: the changing HIV/AIDS epidemic and the criminalization of HIV exposure.
    McArthur JB
    Cornell Law Rev; 2009 Mar; 94(3):707-42. PubMed ID: 19507336
    [No Abstract]   [Full Text] [Related]  

  • 36. Who will bridge the HIV treatment-prevention gap?
    Weis P; Schmid G; De Cock K
    J Infect Dis; 2008 Jul; 198(2):293-4. PubMed ID: 18593296
    [No Abstract]   [Full Text] [Related]  

  • 37. Challenges nurses face in coping with the HIV/AIDS pandemic in Africa.
    Ehlers VJ
    Int J Nurs Stud; 2006 Aug; 43(6):657-62. PubMed ID: 16436278
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
    [No Abstract]   [Full Text] [Related]  

  • 39. "Nothing new": responses to the introduction of antiretroviral drugs in South Africa.
    Chopra M; Kendall C; Hill Z; Schaay N; Nkonki LL; Doherty TM
    AIDS; 2006 Oct; 20(15):1975-7. PubMed ID: 16988520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Universal access to antiretroviral therapy: when, not if.
    Carpenter CC
    Clin Infect Dis; 2006 Jan; 42(2):260-1. PubMed ID: 16355338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.